Schroder Investment Management Group Invitae Corp Transaction History

Schroder Investment Management Group

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $282,116 - $700,349	-44,923 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $87,156 - $169,984	5,929 Added 15.2%	44,923 $686,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $150,940 - $208,622	6,209 Added 18.94%	38,994 $1.11 Million
Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $192,178 - $297,586	7,366 Added 28.98%	32,785 $1.11 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $466,179 - $802,769	14,101 Added 124.59%	25,419 $971,000

Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $217,144 - $318,857	5,555 Added 96.39%	11,318 $473,000
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $55,779 - $87,642	1,962 Added 51.62%	5,763 $245,000
Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $17,740 - $45,889	1,515 Added 66.27%	3,801 $115,000
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $2,039 - $7,342	267 Added 13.22%	2,286 $30,000
Q3 2019 Nov 12, 2019	BUY	$18.85 - $27.5 $38,058 - $55,522	2,019 New	2,019 $38,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.